The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world clinical outcome of sacituzumab govitecan (SG) in HER2-negative metastatic breast cancer.
 
Yuan Yuan
Consulting or Advisory Role - AstraZeneca; Diiachi; Genentech; Merck; Stemline Therapeutics; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Gilead Sciences; Merck
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Jiayi Tan
No Relationships to Disclose
 
David Lin
No Relationships to Disclose
 
Yeonjoo Choi
No Relationships to Disclose
 
Philomena McAndrew
Consulting or Advisory Role - Biotheranostics
 
Dorothy Park
No Relationships to Disclose
 
Niki Tank
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Pfizer
 
Mary El-Masry
No Relationships to Disclose
 
Natasha Banerjee
No Relationships to Disclose
 
Jin Sun Bitar
Research Funding - Bristol Myers Squibb Foundation